Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.6795 per EA under NDC 72205004211. Its NADAC has been published 304 times since Dec 9, 2020.
FDA first approved this application on May 20, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205004211
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212544FDA Approved
5/20/2020
TE Code
AB
On Market Since
8/25/2020
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 304 times since Dec 9, 2020, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6795 per EA |
|---|---|
| All-time high | $3.3508 (Apr 14, 2021) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6282 |
| Median price | $1.1960 |
| Average price | $1.4432 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 304 |
| Tracking since | Dec 9, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oseltamivir phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Novadoz Pharmaceuticals LLC, is $0.6795 per EA (NDC 72205004211), effective Sep 30, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 79.7%. It has been tracked across 304 weekly CMS publications since Dec 9, 2020.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Dec 9, 2020, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $3.3508 (Apr 14, 2021), with a median of $1.1960 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 72205004211) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.